Product image of Mertenil (Rosuvastatin) supplied by GNH India

Mertenil

Active Ingredient:
Rosuvastatin
Origin:
EU

Mertenil (Rosuvastatin)

Rosuvastatin, the active ingredient in Mertenil, is a HMG‑CoA reductase inhibitor presented as a tablet for oral use. It lowers elevated cholesterol levels and is prescribed for adults with hypercholesterolemia and for cardiovascular risk reduction. The medication works by decreasing the synthesis of low‑density lipoprotein cholesterol, helping to prevent atherosclerotic events in patients with established or high risk of heart disease.

GNH India supplies Mertenil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Gedeon Richter Plc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Rosuvastatin is indicated for disorders of lipid metabolism and for cardiovascular disease prevention.

  • Hypercholesterolemia: lowers LDL‑cholesterol and total cholesterol to target levels.
  • Primary prevention of cardiovascular disease: reduces risk of myocardial infarction, stroke and related events in high‑risk patients without prior events.
  • Secondary prevention of cardiovascular disease: decreases recurrence of cardiovascular events in patients with established coronary artery disease or prior stroke.
  • Mixed dyslipidemia: improves the overall lipid profile by reducing triglycerides and increasing HDL‑cholesterol.

How It Works

  • Rosuvastatin competitively inhibits HMG‑CoA reductase, the key enzyme that catalyzes the conversion of HMG‑CoA to mevalonate in the hepatic cholesterol biosynthesis pathway. By blocking this rate‑limiting step, hepatic cholesterol synthesis falls, prompting up‑regulation of LDL receptors and increased clearance of circulating LDL particles, thereby lowering plasma LDL‑cholesterol and total cholesterol concentrations.

Side Effects

Rosuvastatin may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Headache
  • Muscle pain (myalgia)
  • Nausea
  • Elevated liver enzymes

Serious or Rare Side Effects

  • Rhabdomyolysis with possible renal failure
  • Severe liver injury
  • Allergic reactions including anaphylaxis

Precautions & Warnings

When prescribing rosuvastatin, several safety considerations are recommended.

  • Assess liver function: obtain baseline hepatic enzymes before initiating therapy.
  • Monitor lipid levels: check fasting lipid profile periodically to evaluate efficacy.
  • Evaluate renal function: adjust use in patients with severe renal impairment.
  • Avoid use in pregnancy: teratogenic risk; discontinue before conception.
  • Caution in patients with a history of muscle disorders: monitor for myopathy symptoms.
  • Store at room temperature: keep below 25 °C, protect from moisture and light in original packaging.

Avoid Interactions

Rosuvastatin interacts with several medicines that may alter its concentration or increase toxicity.

Major Interactions (Avoid)

  • Concomitant use with cyclosporine: may markedly increase rosuvastatin plasma concentrations.
  • Co‑administration with strong CYP2C9 inhibitors (e.g., fluconazole): raises risk of myopathy.
  • Use with gemfibrozil or other fibrates: heightened chance of rhabdomyolysis.

Moderate Interactions (Monitor Closely)

  • Co‑administration with warfarin: may enhance anticoagulant effect, requiring INR monitoring.
  • Use with antacids containing aluminum or magnesium: can reduce rosuvastatin absorption; separate dosing by at least 2 hours.
  • Concurrent use with niacin: may increase risk of liver enzyme elevations.

Frequently Asked Questions

Mertenil contains rosuvastatin and is used to lower elevated LDL‑cholesterol and total cholesterol in patients with hypercholesterolemia. It is also prescribed to reduce the risk of cardiovascular events in both primary and secondary prevention settings, and to improve lipid profiles in mixed dyslipidemia.

Rosuvastatin blocks the enzyme HMG‑CoA reductase, which is essential for cholesterol synthesis in the liver. This inhibition reduces hepatic cholesterol production, leading to an increase in LDL‑receptor expression and enhanced removal of LDL particles from the bloodstream, thereby lowering plasma cholesterol levels.

The appropriate dose of Mertenil is determined by the prescribing clinician based on the patient’s lipid profile, cardiovascular risk, age, renal function and other clinical factors. Dosage may be adjusted during therapy to achieve target cholesterol levels.

Rosuvastatin is classified as pregnancy category X because it can cause fetal harm. It should not be used during pregnancy, and women of child‑bearing potential must discontinue the drug before conception. Safety during breastfeeding has not been established, so use is generally avoided.

To order Mertenil, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mertenil (rosuvastatin) is a high‑potency, long‑acting statin that often achieves greater LDL‑cholesterol reductions at lower doses compared with older agents such as simvastatin or pravastatin. Its pharmacokinetic profile provides once‑daily dosing, but clinicians consider individual patient factors, drug‑interaction potential and cost when selecting a statin.

Mertenil tablets should be stored at room temperature, below 25 °C, in their original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Mertenil is taken orally, usually once daily, with or without food, as directed by the prescribing healthcare professional. The tablet should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.

The most serious adverse events associated with rosuvastatin include rhabdomyolysis, which can lead to acute renal failure, severe liver injury, and rare hypersensitivity reactions such as anaphylaxis. Patients should promptly report unexplained muscle pain, weakness, dark urine, jaundice or signs of an allergic reaction.

Mertenil should not be used by individuals with active liver disease, unexplained persistent elevations of transaminases, or those who are pregnant or planning pregnancy. It is also contraindicated in patients with known hypersensitivity to rosuvastatin or any component of the formulation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Rosuvastatin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT